Search results
Review select Real-World evidence supplementing the efficacy and safety data from randomized clinical trials. ... (CYP3A4) increase exposure to apixaban and increase the risk of bleeding. For patients receiving ELIQUIS doses of 5 mg or 10 mg twice daily, reduce the dose of ELIQUIS by 50% when ELIQUIS is coadministered with drugs that are ...
4 mar 2021 · A systematic review found that the proportion of correct HCP responses for 69 key safety concerns assessed in 22 studies was above 60% for most (76.8%) and above 80% for some (40.6%) items.
Eliquis User Reviews & Ratings. Eliquis has an average rating of 5.3 out of 10 from a total of 229 reviews on Drugs.com. 36% of reviewers reported a positive experience, while 39% reported a negative experience.
18 mar 2024 · Opinie pacjentów na temat Eliquis są zróżnicowane. Dla niektórych jest to skuteczny lek w zapobieganiu poważnym schorzeniom, takim jak udar mózgu czy zatorowość płucna, przy relatywnie niewielkim ryzyku skutków ubocznych.
Find 152 user ratings and reviews for Eliquis (apixaban) on WebMD including side effects and drug interactions, medication effectiveness, ease of use and satisfaction.
12 wrz 2024 · Opinie na temat leku Eliquis są różne, jednak przeważa pozytywne nastawienie do jego skuteczności w kontroli problemów z krzepnięciem krwi. Niektórzy pacjenci doświadczają skutków ubocznych, takich jak zmęczenie czy krwotoki, co może wymagać zmiany leku lub dodatkowych konsultacji z lekarzem.
The primary objective was to evaluate effectiveness of the RM tools by assessing HCPs' awareness, utilisation, and knowledge. Method: A non-interventional, cross-sectional study of Australian HCPs who received the RM tools and treated >1 patient with apixaban was conducted.
